Shaanxi Kanghui Pharmaceutical Co., Ltd.

SHSE:603139 Stok Raporu

Piyasa değeri: CN¥1.4b

Shaanxi Kanghui Pharmaceutical Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Shaanxi Kanghui Pharmaceutical's earnings have been declining at an average annual rate of -58.5%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 10.1% per year.

Anahtar bilgiler

-58.5%

Kazanç büyüme oranı

-57.6%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi10.9%
Gelir büyüme oranı10.1%
Özkaynak getirisi-10.2%
Net Marj-12.2%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Insufficient Growth At Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Hampers Share Price

Sep 30
Insufficient Growth At Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Hampers Share Price

Market Cool On Shaanxi Kanghui Pharmaceutical Co., Ltd.'s (SHSE:603139) Revenues Pushing Shares 28% Lower

Jun 09
Market Cool On Shaanxi Kanghui Pharmaceutical Co., Ltd.'s (SHSE:603139) Revenues Pushing Shares 28% Lower

Little Excitement Around Shaanxi Kanghui Pharmaceutical Co., Ltd.'s (SHSE:603139) Revenues

Feb 27
Little Excitement Around Shaanxi Kanghui Pharmaceutical Co., Ltd.'s (SHSE:603139) Revenues

Gelir ve Gider Dağılımı

Shaanxi Kanghui Pharmaceutical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SHSE:603139 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 24605-741948
30 Jun 24669-4717910
31 Mar 24677-3316711
31 Dec 23673-2616611
30 Sep 23589-7017110
30 Jun 23518-6417513
31 Mar 23498-6417713
31 Dec 22492-6318112
30 Sep 224833117114
30 Jun 224723516711
31 Mar 224643617210
31 Dec 214433616910
30 Sep 214572617011
30 Jun 214523316511
31 Mar 214283615510
31 Dec 204143414410
30 Sep 20419401448
30 Jun 20422401408
31 Mar 20427391418
31 Dec 19431431438
30 Sep 19432551357
30 Jun 19399521276
31 Mar 19388561277
31 Dec 18376561237
30 Sep 18383601337
30 Jun 183796612810
31 Mar 18383641288
31 Dec 17367631277
30 Sep 17384661334
30 Jun 17386651360
31 Mar 17385651350
31 Dec 16382651330
31 Dec 15380621350
31 Dec 14376631320
31 Dec 13328561140

Kaliteli Kazançlar: 603139 is currently unprofitable.

Büyüyen Kar Marjı: 603139 is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 603139 is unprofitable, and losses have increased over the past 5 years at a rate of 58.5% per year.

Büyüme Hızlandırma: Unable to compare 603139's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: 603139 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-1.2%).


Özkaynak Getirisi

Yüksek ROE: 603139 has a negative Return on Equity (-10.23%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin